A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Loma Linda University Medical Center
Loma Linda, California, United States
- St. Joseph Hospital
Orange, California, United States
- Kaiser Permanente-San Diego
San Diego, California, United States
- Kaiser Permanente Medical Center - Vallejo
Vallejo, California, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- M.D. Anderson Cancer Center - Orlando
Orlando, Florida, United States
- Ccop - Northshore University Healthsystem
Evanston, Illinois, United States
- Edward Hospital
Naperville, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Nortonhealthcare, Inc.
Louisville, Kentucky, United States
- Franklin Square Hospital Center
Baltimore, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Ccop - Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Ccop, William Beaumont Hospital
Royal Oak, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop, Dayton, Oh
Dayton, Ohio, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Allegheny Cancer Center at Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Nsabp Foundation, Inc.
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
- Vermont Cancer Center at University of Vermont
Burlington, Vermont, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Jul 2013
- Completion
- 30 Nov 2014
- Last update posted
- 6 Oct 2021
- Registered enrollment
- 20
- Registry id
- NCT00803647
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.